Results 201 to 210 of about 861,631 (245)
Exploring the Potential of Population-Optimized Red Blood Cell Antigens and Platelet HLA Typing for Homologous Blood Transfusion Detection in Japanese Athletes. [PDF]
Drug Test AnalMomobayashi A, Okano M.
europepmc +1 more source
BeadWatch: Automated Longitudinal Quality Control Monitoring for Luminex Bead-Based Immunoassays in Histocompatibility Laboratories. [PDF]
HLAChen M +5 more
europepmc +1 more source
Identification of a persistent Ascaris-derived Kalirin epitope associated with chronic T cell activation in the lung. [PDF]
PLoS Negl Trop DisWu Y, Versteeg L, Wu MC, Weatherhead JE.
europepmc +1 more source
Detection of RBC-bound antibodies using flow cytometry and their correlation with HLA polymorphism. [PDF]
Front ImmunolUllah A, Liu L, Qi X, Liu H.
europepmc +1 more source
T cells are blind to the dark mechanics of tumors.
Trends OpenFritzsche M, Kruse K.
europepmc +1 more source
Human minor histocompatibility antigens
Current Opinion in Immunology, 1996 Disparities in minor histocompatibility antigens between HLA-matched organ and bone marrow donors and recipients create a potential risk for graft failure and graft-versus-host disease. These conditions necessitate lifelong pharmacological immunosuppression of organ and bone marrow transplant recipients.
Els Goulmy, E Goulmy
exaly +6 more sources
Minors come of age: minor histocompatibility antigens and graft-versus-host disease [PDF]
Biology of Blood and Marrow Transplantation, 2004 Minor histocompatibility antigens (miHA) are responsible for the occurrence of graft-versus-host disease in the setting of a major histocompatibility complex matched sibling allogeneic stem cell transplantation.
Nelson Chao
exaly +2 more sources